Pfizer Appoints New CSO

From DCAT Value Chain Insights (VCI)

By People On The Move posted 09-14-2016 10:24


Pfizer has appointed Dr. Ole Isacson to the position of chief scientific officer of the neuroscience research unit and senior vice president, effective on September 16. Dr. Isacson is a professor of neurology at Harvard Medical School, and will continue to serve in an educational role. He is also a founding director of the Neuroregeneration Institute at McLean Hospital. Dr. Isacson will report directly to Mikael Dolsten, president of worldwide research and development.

Source: Pfizer


Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription